Completed PHASE4 INTERVENTIONAL 2-arm NCT02118870

Short-term Dual Anti Platelet Therapy in Patients With ACS Treated With the COMBO Dual-therapy Stent (REDUCE)

Randomized Evaluation of Short-term DUal Anti Platelet Therapy in Patients With Acute Coronary Syndrome Treated With the COMBO Dual-therapy stEnt

Sponsor: Diagram B.V.

Conditions Acute Coronary Syndrome

Interventions Treatment 360 days DAPT Treatment 90 days DAPT

Updated 8 times since 2017 Last updated: Feb 7, 2019 Started: Jun 10, 2014 Primary completion: Sep 30, 2017 Completion: Sep 30, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Acute Coronary Syndrome and is currently completed. Diagram B.V. leads this study, which shows 8 recorded versions since 2014 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Mar 2019 — Jan 2021 [monthly]

Completed PHASE4

Status: Active Not Recruiting → Completed
Jun 2018 — Mar 2019 [monthly]

Active Not Recruiting PHASE4

▶ Show 3 earlier versions

Oct 2017 — Jun 2018 [monthly]

Active Not Recruiting PHASE4
Feb 2017 — Oct 2017 [monthly]

Active Not Recruiting PHASE4
Jan 2017 — Feb 2017 [monthly]

Active Not Recruiting PHASE4

First recorded

Jun 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Diagram B.V.

Data source: Diagram B.V.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.